Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Assets Current | |||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | 1 | 1 | 2 | 1 | 2 | 1 | |||||
Prepaid Expense Noncurrent | - | - | 0 | 0 | 0 | 0 | |||||
Assets Held In Trust Noncurrent | 205 | 203 | 202 | 200 | 198 | 196 | |||||
Assets | 207 | 205 | 203 | 201 | 199 | 197 | |||||
Liabilities And Stockhold… | |||||||||||
Liabilities Current | |||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 0 | 0 | 0 | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Liabilities | 9 | 9 | 8 | 8 | 8 | 8 | |||||
Temporary Equity Carrying Amount Attributable To P… | 205 | 203 | 202 | 200 | 198 | 196 | |||||
Stockholders Equity | |||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -7 | -7 | -7 | -7 | -7 | -7 | |||||
Stockholders Equity | -7 | -7 | -7 | -7 | -7 | -7 | |||||
Liabilities And Stockholders Equity | 207 | 205 | 203 | 201 | 199 | 197 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.09% | 0.94% | 1.03% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.67% | -0.18% | 0.10% | 0.87% | 1.83% | 2.12% | 0.19% | 0.62% | 0.95% | -0.09% | -0.09% | 0.09% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Oaktree Acquisition Corp. III Life Sciences (OACC) — SEC Financial Statements & Analysis
Oaktree Acquisition Corp. III Life Sciences (OACC) is a blank checks company, incorporated in E9. Oaktree Acquisition Corp. III Life Sciences trades on Nasdaq as: OACC, OACCU, OACCW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Oaktree Acquisition Corp. III Life Sciences reported a Debt-to-Equity ratio of -1.17x, a Price-to-Book (P/B) ratio of -28.11x (TTM), at a market cap of $203.13M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.17x
- P/B TTM
- -28.11x
- Market Cap
- $203.13M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Oaktree Acquisition Corp. III Life Sciences in?
Oaktree Acquisition Corp. III Life Sciences (OACC) operates in the Blank Checks industry.
What is OACC's market cap?
Oaktree Acquisition Corp. III Life Sciences (OACC) has a market capitalization of $203.13M as of 2026-03-31.
What is OACC's P/E ratio?
Oaktree Acquisition Corp. III Life Sciences (OACC)'s trailing twelve month P/E ratio is 28.92x as of 2026-03-31.
What exchange does OACC trade on?
Oaktree Acquisition Corp. III Life Sciences (OACC) trades on the Nasdaq.
Where is Oaktree Acquisition Corp. III Life Sciences incorporated?
Oaktree Acquisition Corp. III Life Sciences is incorporated in Cayman Islands.